ANDREW HULL SEC EDGAR Filings (CIK 0001818252)

SEC EDGAR filings, ownership reports, and insider transactions for ANDREW HULL.

Business address
C/O Inmed Pharmaceuticals Inc., Suite 310 815 Hastings Street, Vancouver, British Columbia, Canada, V6C 1B4
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
ANDREW HULL has filed 12 SEC EDGAR filings since 12 Nov 2020

Latest Filings

Recent SEC filings for ANDREW HULL including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 19 Dec 2025 19 Dec 2025 001-39685
4 Open 4 document View SEC filing for 4 17 Dec 2025 15 Dec 2025 001-39685
4 Open 4 document View SEC filing for 4 03 Feb 2025 11 Jan 2025 001-39685
4 Open 4 document View SEC filing for 4 23 Dec 2024 20 Dec 2024 001-39685
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 05 Mar 2024 14 Jan 2024 001-39685
4 Open 4 document View SEC filing for 4 22 Feb 2024 21 Feb 2024 001-39685
4 Open 4 document View SEC filing for 4 26 Dec 2023 23 Dec 2023 001-39685
4 Open 4 document View SEC filing for 4 19 Dec 2022 16 Dec 2022 001-39685
4 Open 4 document View SEC filing for 4 24 Jan 2022 24 Jan 2022 001-39685
4 Open 4 document View SEC filing for 4 30 Dec 2021 29 Dec 2021 001-39685
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 18 Dec 2020 16 Dec 2020 001-39685
3 Open 3 document View SEC filing for 3 FORM 3 12 Nov 2020 12 Nov 2020 001-39685

About this filer

ANDREW HULL files with the SEC under CIK 0001818252. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages